aTYR PHARMA INC

Ownership Transactions Reported by 10 Insiders

Symbol
ATYR on Nasdaq
Location
10240 Sorrento Valley Road, Suite 300, San Diego, CA

Insiders trading volume in the past year

aTYR PHARMA INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul Schimmel Director $815K +$185K +29.3% Jul 22, 2024
Sanjay Shukla President and CEO, Director $282K +$36.1K +14.7% Jan 8, 2025
Timothy Coughlin Director $98K +$87.5K +833% May 30, 2024
Jill Marie Broadfoot Chief Financial Officer $58.9K +$6.26K +11.9% Jan 8, 2025
Nancy Denyes General Counsel $47.6K +$9.28K +24.2% Jan 8, 2025
Svetlana Lucas Director May 22, 2024
John K. Clarke Director May 22, 2024
Sara Zaknoen Director May 22, 2024
Jane A. Gross Director May 22, 2024
Eric Benevich Director Dec 10, 2024

Recent Insider Transactions by Companies or Individuals for aTYR PHARMA INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.